JP2014527887A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527887A5 JP2014527887A5 JP2014532378A JP2014532378A JP2014527887A5 JP 2014527887 A5 JP2014527887 A5 JP 2014527887A5 JP 2014532378 A JP2014532378 A JP 2014532378A JP 2014532378 A JP2014532378 A JP 2014532378A JP 2014527887 A5 JP2014527887 A5 JP 2014527887A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery device
- drug delivery
- view
- housing
- cartridge holder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012377 drug delivery Methods 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 6
- 238000003466 welding Methods 0.000 description 4
- 208000002249 Diabetes Complications Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 2
- 102000002265 Human Growth Hormone Human genes 0.000 description 2
- 108010000521 Human Growth Hormone Proteins 0.000 description 2
- 239000000854 Human Growth Hormone Substances 0.000 description 2
- 208000001435 Thromboembolism Diseases 0.000 description 2
- JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 2
- 108010015174 exendin 3 Proteins 0.000 description 2
- LMHMJYMCGJNXRS-IOPUOMRJSA-N exendin-3 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@H](C)O)[C@H](C)O)C(C)C)C1=CC=CC=C1 LMHMJYMCGJNXRS-IOPUOMRJSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229960004532 somatropin Drugs 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010037003 Buserelin Proteins 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010011459 Exenatide Proteins 0.000 description 1
- 102400000932 Gonadoliberin-1 Human genes 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 108010069236 Goserelin Proteins 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 101500026183 Homo sapiens Gonadoliberin-1 Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 108010024118 Hypothalamic Hormones Proteins 0.000 description 1
- 102000015611 Hypothalamic Hormones Human genes 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 108010021717 Nafarelin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010047386 Pituitary Hormones Proteins 0.000 description 1
- 102000006877 Pituitary Hormones Human genes 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 108010050144 Triptorelin Pamoate Proteins 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- CUWODFFVMXJOKD-UVLQAERKSA-N buserelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960001519 exenatide Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960001442 gonadorelin Drugs 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229960002913 goserelin Drugs 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 229940043650 hypothalamic hormone Drugs 0.000 description 1
- 239000000601 hypothalamic hormone Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- RWHUEXWOYVBUCI-ITQXDASVSA-N nafarelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 RWHUEXWOYVBUCI-ITQXDASVSA-N 0.000 description 1
- 229960002333 nafarelin Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960004824 triptorelin Drugs 0.000 description 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11183300.0 | 2011-09-29 | ||
| EP11183300 | 2011-09-29 | ||
| PCT/EP2012/069032 WO2013045527A1 (en) | 2011-09-29 | 2012-09-27 | Drug delivery device and method for a drug delivery device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014527887A JP2014527887A (ja) | 2014-10-23 |
| JP2014527887A5 true JP2014527887A5 (cg-RX-API-DMAC10.html) | 2015-11-12 |
| JP6251172B2 JP6251172B2 (ja) | 2017-12-20 |
Family
ID=46924450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014532378A Active JP6251172B2 (ja) | 2011-09-29 | 2012-09-27 | 薬物送達デバイスおよび薬物送達デバイスに対する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9707352B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2760507B8 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6251172B2 (cg-RX-API-DMAC10.html) |
| AR (1) | AR088084A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2848181A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK2760507T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2581503T3 (cg-RX-API-DMAC10.html) |
| HU (1) | HUE029364T2 (cg-RX-API-DMAC10.html) |
| PL (1) | PL2760507T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013045527A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2414400B (en) | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
| GB2414402B (en) | 2004-05-28 | 2009-04-22 | Cilag Ag Int | Injection device |
| GB2414775B (en) | 2004-05-28 | 2008-05-21 | Cilag Ag Int | Releasable coupling and injection device |
| GB2425062B (en) | 2005-04-06 | 2010-07-21 | Cilag Ag Int | Injection device |
| GB2424836B (en) | 2005-04-06 | 2010-09-22 | Cilag Ag Int | Injection device (bayonet cap removal) |
| US20110098656A1 (en) | 2005-09-27 | 2011-04-28 | Burnell Rosie L | Auto-injection device with needle protecting cap having outer and inner sleeves |
| GB2438591B (en) | 2006-06-01 | 2011-07-13 | Cilag Gmbh Int | Injection device |
| GB2461085B (en) | 2008-06-19 | 2012-08-29 | Cilag Gmbh Int | Injection device |
| US8986259B2 (en) * | 2010-03-31 | 2015-03-24 | Sanofi-Aventis Deutschland Gmbh | Piston rod assembly for a drug delivery device |
| DK2983746T3 (da) * | 2013-04-10 | 2020-03-23 | Sanofi Sa | Injektionsanordning og fremgangsmåde til samling |
| GB2515039B (en) | 2013-06-11 | 2015-05-27 | Cilag Gmbh Int | Injection Device |
| GB2517896B (en) | 2013-06-11 | 2015-07-08 | Cilag Gmbh Int | Injection device |
| GB2515038A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Injection device |
| GB2515032A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Guide for an injection device |
| CN112545886A (zh) | 2015-03-10 | 2021-03-26 | 里珍纳龙药品有限公司 | 无菌刺穿系统和方法 |
| EP3274024B1 (en) * | 2015-03-23 | 2021-01-20 | Sanofi-Aventis Deutschland GmbH | Housing for an injection device and interconnection of housing components |
| JP6840092B2 (ja) | 2015-07-01 | 2021-03-10 | ノボ・ノルデイスク・エー／エス | 薬剤送達装置を組み立てる方法およびその方法により形成される薬剤送達装置 |
| CA3055583A1 (en) | 2017-05-05 | 2018-11-08 | Regeneron Pharmaceuticals, Inc. | Auto-injector |
| CA3175774A1 (en) | 2017-10-16 | 2019-04-25 | Becton, Dickinson And Company | Spacer assembly for drug delivery device |
| USD1007676S1 (en) | 2021-11-16 | 2023-12-12 | Regeneron Pharmaceuticals, Inc. | Wearable autoinjector |
| WO2024259313A1 (en) | 2023-06-16 | 2024-12-19 | Regeneron Pharamceuticals, Inc. | Medical device packaging and related methods |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4492576A (en) * | 1982-06-15 | 1985-01-08 | Dragan William B | Dental syringe and method of packaging and dispensing a dental material |
| US5279585A (en) | 1992-02-04 | 1994-01-18 | Becton, Dickinson And Company | Medication delivery pen having improved dose delivery features |
| US5584815A (en) * | 1993-04-02 | 1996-12-17 | Eli Lilly And Company | Multi-cartridge medication injection device |
| US5514097A (en) * | 1994-02-14 | 1996-05-07 | Genentech, Inc. | Self administered injection pen apparatus and method |
| US5688251A (en) * | 1995-09-19 | 1997-11-18 | Becton Dickinson And Company | Cartridge loading and priming mechanism for a pen injector |
| GB0304823D0 (en) * | 2003-03-03 | 2003-04-09 | Dca Internat Ltd | Improvements in and relating to a pen-type injector |
| GB0304822D0 (en) * | 2003-03-03 | 2003-04-09 | Dca Internat Ltd | Improvements in and relating to a pen-type injector |
| SI1656170T1 (sl) * | 2003-08-12 | 2019-05-31 | Eli Lilly And Company | Oprema za izdajanje zdravil s trojnim vijačnim navojem za mehanski pospešek |
| DE10351597A1 (de) * | 2003-11-05 | 2005-06-16 | Tecpharma Licensing Ag | Vorrichtung für die Verabreichung eines injizierbaren Produkts |
| AU2005231731B2 (en) * | 2004-03-30 | 2010-12-23 | Eli Lilly And Company | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose |
| DE602005026595D1 (de) * | 2004-12-01 | 2011-04-07 | Novo Nordisk As | Injektionsvorrichtung |
| TWI294782B (en) * | 2006-01-27 | 2008-03-21 | Bencha Internat Group Inc | Medically safety injector with a collapsable plunger combination thereof |
| EP1923083A1 (en) | 2006-11-17 | 2008-05-21 | Sanofi-Aventis Deutschland GmbH | Drive mechanisms for use in drug delivery devices |
| US7627572B2 (en) * | 2007-05-02 | 2009-12-01 | Mypoints.Com Inc. | Rule-based dry run methodology in an information management system |
| ES2531907T3 (es) * | 2008-01-28 | 2015-03-20 | Novo Nordisk A/S | Dispositivo de inyección para realizar inyecciones médicas |
| TWI555546B (zh) | 2008-12-02 | 2016-11-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物傳輸裝置及其操作方法 |
| US9545483B2 (en) * | 2008-12-02 | 2017-01-17 | Sanofi-Aventis Deutschland Gmbh | Drive assembly suitable for use in a medication delivery device and medication delivery device |
| US20120071836A1 (en) * | 2009-04-30 | 2012-03-22 | Sanofi-Aventis Deutschland Gmbh | Drive mechanism for a drug delivery device |
| DK2482891T3 (en) * | 2009-09-30 | 2017-02-06 | Sanofi Aventis Deutschland | RETRIEVABLE DRIVING AND PHARMACEUTICAL SUPPLY |
| DK2482872T4 (da) * | 2009-09-30 | 2020-03-02 | Sanofi Aventis Deutschland | Fremgangsmåde til samling af en lægemiddelfremføringsanordning, indretning til en lægemiddelfremføringsanordning og stempelstang til en lægemiddelfremføringsanordning |
| CN102648013B (zh) * | 2009-09-30 | 2015-12-16 | 赛诺菲-安万特德国有限公司 | 可重设药物输送装置 |
| DK2493531T4 (da) * | 2009-10-30 | 2023-05-01 | Sanofi Aventis Deutschland | Lægemiddelfremføringsindretninger og fremgangsmåde til samling |
| US8491536B2 (en) | 2009-12-15 | 2013-07-23 | Shl Group Ab | Medicament delivery device |
| BR112012023431A2 (pt) * | 2010-03-16 | 2017-10-24 | Sanofi Aventis Deutschland | dispositivo de distribuição de fármacos |
| US8986259B2 (en) * | 2010-03-31 | 2015-03-24 | Sanofi-Aventis Deutschland Gmbh | Piston rod assembly for a drug delivery device |
-
2012
- 2012-09-27 WO PCT/EP2012/069032 patent/WO2013045527A1/en not_active Ceased
- 2012-09-27 DK DK12762612.5T patent/DK2760507T3/en active
- 2012-09-27 CA CA2848181A patent/CA2848181A1/en not_active Abandoned
- 2012-09-27 HU HUE12762612A patent/HUE029364T2/en unknown
- 2012-09-27 EP EP12762612.5A patent/EP2760507B8/en active Active
- 2012-09-27 JP JP2014532378A patent/JP6251172B2/ja active Active
- 2012-09-27 ES ES12762612.5T patent/ES2581503T3/es active Active
- 2012-09-27 PL PL12762612.5T patent/PL2760507T3/pl unknown
- 2012-09-27 AR ARP120103599A patent/AR088084A1/es not_active Application Discontinuation
- 2012-09-27 US US14/346,507 patent/US9707352B2/en active Active
-
2017
- 2017-06-13 US US15/620,993 patent/US10376650B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516700A5 (cg-RX-API-DMAC10.html) | ||
| JP2014519900A5 (cg-RX-API-DMAC10.html) | ||
| JP2014516702A5 (cg-RX-API-DMAC10.html) | ||
| JP2014516701A5 (cg-RX-API-DMAC10.html) | ||
| JP6031084B2 (ja) | 枢動保護キャップを備えた薬物送達デバイス | |
| JP6356698B2 (ja) | 薬物送達デバイス | |
| JP6367829B2 (ja) | プランジャの位置を検出する装置 | |
| JP5613688B2 (ja) | 折り畳み可能な指パッドを有する薬物送達デバイス | |
| JP2013506460A (ja) | 薬物送達デバイス用の方法及び組立体 | |
| JP5716031B2 (ja) | 薬物送達デバイス用の方法及び組立体 | |
| JP5794992B2 (ja) | クリアランス補償手段を備えた薬物送達デバイス | |
| ES2681421T3 (es) | Componente de soporte para una varilla del pistón de un dispositivo de administración de fármacos, varilla del pistón que comprende el componente de soporte y dispositivo de administración de fármacos. | |
| JP5656972B2 (ja) | ペンキャップ | |
| JP5586633B2 (ja) | 後退可能な針を備えた薬物送達デバイス | |
| JP2013514100A (ja) | 最大用量制限エレメントを備えた用量設定機構 | |
| EP3380140A1 (en) | Auto-injector | |
| JP2013506458A (ja) | 薬物送達デバイス、薬物送達デバイス用の組立体及び薬物送達デバイス用のピストンロッドを組み立てる方法 | |
| CN105682707A (zh) | 具有两个驱动弹簧的药剂输送装置 | |
| JP2006519076A5 (cg-RX-API-DMAC10.html) | ||
| JP2013514101A (ja) | カートリッジ用ピストン及び薬物送達デバイス用ピストンロッド | |
| JP5841591B2 (ja) | 薬物送達デバイスの構成部材を輸送及び／又は貯蔵するためのワークピースキャリア | |
| JP7344223B2 (ja) | 注射デバイスにおける力の低減 | |
| JP5777605B2 (ja) | 薬物送達デバイス用の複合工作物の製造方法 | |
| KR20160018734A (ko) | 주사 장치용 가이드 | |
| CN115297915A (zh) | 用于药物递送装置的电子系统 |